Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients

2017 ◽  
Vol 19 (2) ◽  
pp. e12675 ◽  
Author(s):  
Jameela Edathodu ◽  
Bright Varghese ◽  
Abdulrahman A Alrajhi ◽  
Mohammed Shoukri ◽  
Ahmad Nazmi ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Interferon Gamma ◽  
Latent Tuberculosis Infection ◽  
Latent Tuberculosis ◽  
Tuberculosis Infection ◽  
Interferon Gamma Release Assay ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Diagnostic Potential ◽  
Release Assay

scholarly journals Interferon Gamma Release Assay for Identifying Latent Tuberculosis Infection in People With Bacillus Calmette-Guérin Vaccination

2021 ◽  
Vol 1 (5) ◽  
Author(s):  
Kendra Brett ◽  
Melissa Severn
Keyword(s):  
Interferon Gamma ◽  
Latent Tuberculosis Infection ◽  
Randomized Study ◽  
Latent Tuberculosis ◽  
Tuberculosis Infection ◽  
Interferon Gamma Release Assay ◽  
Bacillus Calmette Guerin ◽  
Release Assay ◽  
Tuberculosis Therapy ◽  
Evidence Based Guidelines

In people who have been vaccinated with Bacillus Calmette-Guérin, the interferon gamma release assay appears to be related to fewer diagnoses for latent tuberculosis infection, fewer prescriptions of preventive tuberculosis therapy, and no difference in the number of active TB cases compared to the tuberculin skin test (findings based on 1 [non-randomized study] of low quality). No evidence-based guidelines were found regarding the identification of latent tuberculosis infection in people with previous Bacillus Calmette-Guérin vaccination.

Sign in / Sign up

Export Citation Format

Share Document